AORT(AORT)
AORT
Q4 2026 EPS Estimate
$0.11
Nov 5, 2026 · Reports after close
Revenue Estimate
$121M
FY2026E EPS$0.08
FY2027E EPS$0.41
Analyst Sentiment
Wall St. Consensus
Buy12 analysts·Moderate coverage
71
Score
10 Buy (83%)2 Hold (17%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1083%
Hold
217%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$40.00
+38.5%
Consensus
$42.50
+47.2%
Bull
$45.00
+55.8%
12-Month Target Range12 analysts
$40.00$42.50$45.00
Current $28.88Consensus
Current Price
$28.88
Upside to Consensus
$13.62
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+11.02%
EPS+386.57%
FY2028
Rev+11.30%
EPS+93.87%
FY2029
Rev+12.83%
EPS+50.63%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $486M | $540M | $601M | $678M | $764M |
| Low | $485M | $533M | $582M | $664M | $748M |
| High | $488M | $547M | $622M | $691M | $778M |
| EBITDA Avg | $51M | $56M | $63M | $71M | $80M |
| Low | $50M | $55M | $61M | $69M | $78M |
| High | $51M | $57M | $65M | $72M | $81M |
| EBIT Avg | $19M | $21M | $23M | $26M | $29M |
| Low | $18M | $20M | $22M | $25M | $28M |
| High | $19M | $21M | $24M | $26M | $30M |
| Net Income Avg | $4M | $19M | $37M | $56M | $74M |
| Low | $4M | $19M | $34M | $55M | $72M |
| High | $4M | $20M | $40M | $57M | $76M |
| EPS Avg | $0.08 | $0.41 | $0.79 | $1.19 | $1.57 |
| Low | $0.08 | $0.40 | $0.73 | $1.16 | $1.53 |
| High | $0.09 | $0.42 | $0.85 | $1.22 | $1.61 |
| Analysts (Rev / EPS) | 6 / 5 | 6 / 5 | 4 / 4 | 2 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $121M | $128M | $129M | $133M | $135M | $143M | $143M | $148M |
| Low | $119M | $126M | $127M | $131M | $132M | $140M | $140M | $145M |
| High | $124M | $130M | $132M | $136M | $138M | $145M | $146M | $151M |
| EBITDA Avg | $13M | $13M | $13M | $14M | $14M | $15M | $15M | $15M |
| Low | $12M | $13M | $13M | $14M | $14M | $15M | $15M | $15M |
| High | $13M | $14M | $14M | $14M | $14M | $15M | $15M | $16M |
| EBIT Avg | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M |
| Low | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M |
| High | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M |
| Net Income Avg | $-121,352 | $3M | $3M | $5M | $6M | $8M | $7M | $8M |
| Low | $-124,329 | $2M | $3M | $5M | $6M | $8M | $7M | $8M |
| High | $-118,300 | $5M | $3M | $5M | $6M | $8M | $7M | $8M |
| EPS Avg | $-0.00 | $0.05 | $0.07 | $0.10 | $0.12 | $0.17 | $0.14 | $0.17 |
| Low | $-0.00 | $0.04 | $0.07 | $0.10 | $0.11 | $0.16 | $0.14 | $0.17 |
| High | $-0.00 | $0.10 | $0.07 | $0.11 | $0.12 | $0.17 | $0.14 | $0.17 |
| Analysts (Rev / EPS) | 5 / 3 | 8 / 6 | 4 / 2 | 5 / 2 | 4 / 2 | 5 / 2 | 3 / 5 | 4 / 5 |